✦ LIBER ✦

Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): Multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety

✍ Scribed by J.J. Hofstra; I. Kleine Budde; E. van Twuyver; G. Choi; M. Levi; F.W.G. Leebeek; J.G.R. de Monchy; P.F. Ypma; R.J. Keizer; A.D.R. Huitema; P.F.W. Strengers

Book ID: 113542050
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 477 KB
Volume: 142
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2011.11.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised, placebo-controlled, double

A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema

✍ Marco Cicardi; Roberto Perricone; Mauro Cancian; Vincenzo Montinaro; Enrico Cill 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Treatment of Acute Abdominal and Facial

Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema (HAE) with Human C1 Esterase Inhibitor (C1-INH): Results of a Global, Multicenter, Randomized, Placebo-controlled, Phase II/III Study (I.M.P.A.C.T.1)

✍ Bernstein, J.A.; Levy, R.; Wasserman, R.L.; Bewtra, A.; Hurewitz, D.; Obtulowicz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 42 KB